These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28344893)

  • 21. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
    Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA
    Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
    Riaz N; Havel JJ; Makarov V; Desrichard A; Urba WJ; Sims JS; Hodi FS; Martín-Algarra S; Mandal R; Sharfman WH; Bhatia S; Hwu WJ; Gajewski TF; Slingluff CL; Chowell D; Kendall SM; Chang H; Shah R; Kuo F; Morris LGT; Sidhom JW; Schneck JP; Horak CE; Weinhold N; Chan TA
    Cell; 2017 Nov; 171(4):934-949.e16. PubMed ID: 29033130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
    Ikeda Y; Kiyotani K; Yew PY; Sato S; Imai Y; Yamaguchi R; Miyano S; Fujiwara K; Hasegawa K; Nakamura Y
    Oncol Rep; 2017 May; 37(5):2603-2610. PubMed ID: 28358435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of
    Ren L; Matsuda T; Deng B; Kiyotani K; Kato T; Park JH; Seiwert TY; Vokes EE; Agrawal N; Nakamura Y
    Oncotarget; 2018 Jan; 9(3):3805-3814. PubMed ID: 29423084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma.
    Xu X; Cheng L; Fan Y; Mao W
    Front Oncol; 2020; 10():544789. PubMed ID: 33042835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells.
    Boddupalli CS; Bar N; Kadaveru K; Krauthammer M; Pornputtapong N; Mai Z; Ariyan S; Narayan D; Kluger H; Deng Y; Verma R; Das R; Bacchiocchi A; Halaban R; Sznol M; Dhodapkar MV; Dhodapkar KM
    JCI Insight; 2016 Dec; 1(21):e88955. PubMed ID: 28018970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing.
    Hylebos M; Van Camp G; van Meerbeeck JP; Op de Beeck K
    J Thorac Oncol; 2016 Oct; 11(10):1615-26. PubMed ID: 27282309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
    Hiltbrunner S; Mannarino L; Kirschner MB; Opitz I; Rigutto A; Laure A; Lia M; Nozza P; Maconi A; Marchini S; D'Incalci M; Curioni-Fontecedro A; Grosso F
    Front Oncol; 2021; 11():660039. PubMed ID: 34249695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.
    Zhang AW; McPherson A; Milne K; Kroeger DR; Hamilton PT; Miranda A; Funnell T; Little N; de Souza CPE; Laan S; LeDoux S; Cochrane DR; Lim JLP; Yang W; Roth A; Smith MA; Ho J; Tse K; Zeng T; Shlafman I; Mayo MR; Moore R; Failmezger H; Heindl A; Wang YK; Bashashati A; Grewal DS; Brown SD; Lai D; Wan ANC; Nielsen CB; Huebner C; Tessier-Cloutier B; Anglesio MS; Bouchard-Côté A; Yuan Y; Wasserman WW; Gilks CB; Karnezis AN; Aparicio S; McAlpine JN; Huntsman DG; Holt RA; Nelson BH; Shah SP
    Cell; 2018 Jun; 173(7):1755-1769.e22. PubMed ID: 29754820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types.
    Tazzari M; Brich S; Tuccitto A; Bozzi F; Beretta V; Spagnuolo RD; Negri T; Stacchiotti S; Deraco M; Baratti D; Camisaschi C; Villa A; Vergani B; Rivoltini L; Pilotti S; Castelli C
    J Immunol Res; 2018; 2018():5804230. PubMed ID: 30510965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival.
    Bahnasy AA; El-Din RS; Sabri NA; Abdel-Rahman CA; Bastawisy AE
    Cancer Genet; 2018 Dec; 228-229():83-92. PubMed ID: 30553477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination.
    Yang K; Yang T; Yang T; Yuan Y; Li F
    Front Oncol; 2022; 12():995651. PubMed ID: 36237331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 34. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer.
    Safonov A; Jiang T; Bianchini G; Győrffy B; Karn T; Hatzis C; Pusztai L
    Cancer Res; 2017 Jun; 77(12):3317-3324. PubMed ID: 28428277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
    Naka T; Hatanaka Y; Marukawa K; Okada H; Hatanaka KC; Sakakibara-Konishi J; Oizumi S; Hida Y; Kaga K; Mitsuhashi T; Matsuno Y
    Diagn Pathol; 2016 Apr; 11():38. PubMed ID: 27091358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.
    De Rienzo A; Archer MA; Yeap BY; Dao N; Sciaranghella D; Sideris AC; Zheng Y; Holman AG; Wang YE; Dal Cin PS; Fletcher JA; Rubio R; Croft L; Quackenbush J; Sugarbaker PE; Munir KJ; Battilana JR; Gustafson CE; Chirieac LR; Ching SM; Wong J; Tay LC; Rudd S; Hercus R; Sugarbaker DJ; Richards WG; Bueno R
    Cancer Res; 2016 Jan; 76(2):319-28. PubMed ID: 26554828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
    van den Bulk J; Verdegaal EME; Ruano D; Ijsselsteijn ME; Visser M; van der Breggen R; Duhen T; van der Ploeg M; de Vries NL; Oosting J; Peeters KCMJ; Weinberg AD; Farina-Sarasqueta A; van der Burg SH; de Miranda NFCC
    Genome Med; 2019 Dec; 11(1):87. PubMed ID: 31888734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes.
    Klampatsa A; O'Brien SM; Thompson JC; Rao AS; Stadanlick JE; Martinez MC; Liousia M; Cantu E; Cengel K; Moon EK; Singhal S; Eruslanov EB; Albelda SM
    Oncoimmunology; 2019; 8(9):e1638211. PubMed ID: 31428531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
    Hylebos M; Op de Beeck K; Pauwels P; Zwaenepoel K; van Meerbeeck JP; Van Camp G
    Lung Cancer; 2018 Oct; 124():19-22. PubMed ID: 30268460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.